[an error occurred while processing this directive]
综述

硫酸吲哚酚与慢性肾脏病及其并发症的研究进展

  • 杨靖宇 ,
  • 方敬爱 ,
  • 张晓东 ,
  • 刘文媛 ,
  • 张紫媛 ,
  • 胡雅玲
展开
  • 030001 太原,1山西医科大学第一临床医学院
    030001 太原,2山西医科大学第一医院肾内科

收稿日期: 2022-04-07

  修回日期: 2022-06-29

  网络出版日期: 2022-10-12

基金资助

国家自然科学青年基金(81803947);山西省面上青年基金(201901D211484)

Research progress in the effects of indoxyl sulfate on chronic kidney disease and its complications   

  • YANG Jing-Yu ,
  • FANG Jing-Ai ,
  • ZHANG Xiao-Dong ,
  • LIU Wen-Yuan ,
  • ZHANG Zi-Yuan ,
  • HU Ya-Ling
Expand
  • The First Clinical Medical College of Shanxi Medical University, Taiyuan 030001, China; 2Department of Nephrology, Shanxi Medical University First Hospital, Taiyuan 030001, China

Received date: 2022-04-07

  Revised date: 2022-06-29

  Online published: 2022-10-12

摘要

硫酸吲哚酚(indoxyl sulfate,IS)是一种肠源性尿毒症毒素,近些年的研究表明IS在体内积聚不仅会导致慢性肾脏病(chronic kidney disease,CKD)进展,还参与CKD患者心血管疾病、肌肉减少症、认知功能障碍、骨病及贫血等多种并发症的进展,从而降低患者的生活质量及生存率,故本文将围绕近年来IS与CKD及其并发症的相关研究来展开综述,旨在为CKD的防治提供新思路。

本文引用格式

杨靖宇 , 方敬爱 , 张晓东 , 刘文媛 , 张紫媛 , 胡雅玲 . 硫酸吲哚酚与慢性肾脏病及其并发症的研究进展[J]. 中国血液净化, 2022 , 21(10) : 754 -757 . DOI: 10.3969/j.issn.1671-4091.2022.10.011

Abstract

Indoxyl sulfate (IS) is a uremic toxin of intestinal origin. Recent studies have shown that the accumulation of IS in the body will not only lead to the progression of chronic kidney disease (CKD), but also participate in the progression of cardiovascular disease, sarcopenia, cognitive impairment, osteopathy and anemia in CKD patients, thus reducing the quality of life and survival rate of CKD patients. This paper reviews the studies relating to the effects of IS on CKD and its complications in recent years, in order to provide new ideas for the prevention and intervention of CKD.

参考文献

[1]Lin C N, Wu I W, Huang Y F, et al.Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MSMS[J].J Food Drug Anal, 2019, 27(2):502-509

[2] Cheng T H, Ma M C, Liao M T, et al.Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease[J].Toxins (Basel), 2020, 12(11):684

[3]Holle J, Kirchner M, Okun J, et al.Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children[J].PLoS One, 2020, 15(10):e0240446

[4]Yamamoto S, Fuller D S, Komaba H, et al.Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study[J].Clin Kidney J, 2021, 14(4):1236-1243

[5]Kikuchi K, Saigusa D, Kanemitsu Y, et al.Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease[J].Nat Commun, 2019, 10(1):1835

[6]Ellis R J, Small D M, Ng K L, et al.Indoxyl Sulfate Induces Apoptosis and Hypertrophy in Human Kidney Proximal Tubular Cells[J].Toxicol Pathol, 2018, 46(4):449-459

[7] Lu C L, Liao C H, Lu K C, et al.TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage[J]. Int J Mol Sci, 2020, 21(17):6212

[8]Bolati D, Shimizu H, Yisireyili M, et al.Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-kappaB[J].BMC Nephrol, 2013, 14:56

[9]Shimizu H, Saito S, Higashiyama Y, et al.CREB,NF-kappaB,and NADPH oxidase coordinately upregulate indoxyl sulfate-induced angiotensinogen expression in proximal tubular cells[J].Am J Physiol Cell Physiol, 2013, 304(7):C685-92

[10]Lu C L, Zheng C M, Lu K C, et al.Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease[J].Antioxidants (Basel), 2021, 10(6):936

[11]Barreto F C, Barreto D V, Liabeuf S, et al.Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients[J].Clin J Am Soc Nephrol, 2009, 4(10):1551-8

[12]Holle J, Querfeld U, Kirchner M, et al.Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease[J].Pediatr Nephrol, 2019, 34(12):2571-2582

[13]Wu C C, Hsieh M Y, Hung S C, et al.Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts[J].J Am Soc Nephrol, 2016, 27(4):1254-64

[14]Li S Z, Xie Y F, Yang B Y, et al.MicroRNA-214 targets COX-2 to antagonize indoxyl sulfate (IS)-induced endothelial cell apoptosis[J].Apoptosis, 2020, 25(1-2):92-104

[15] Kim H Y, Yoo T H, Hwang Y, et al.Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)[J].Scientific Reports, 2017, 7(1):3057

[16]Garcia-Jerez A, Luengo A, Carracedo J, et al.Effect of uraemia on endothelial cell damage is mediated by the integrin linked kinase pathway[J].Journal of Physiology-London, 2015, 593(3):601-618

[17]Ito S, Osaka M, Edamatsu T, et al.Crucial Role of the Aryl Hydrocarbon Receptor (AhR) in Indoxyl Sulfate-Induced Vascular Inflammation[J].Journal of Atherosclerosis and Thrombosis, 2016, 23(8):960-975

[18]He X, Jiang H L, Gao F F, et al.Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3KAktNF-kappa B signaling pathway[J].Microscopy Research and Technique, 2019, 82(12):2000-2006

[19] Savira F, Cao L X, Wang I, et al.Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome[J].Plos One, 2017, 12(11):e0187459

[20]Watanabe H, Enoki Y, Maruyama T.Sarcopenia in Chronic Kidney Disease: Factors,Mechanisms,and Therapeutic Interventions[J].Biol Pharm Bull, 2019, 42(9):1437-1445

[21]Lin Y L, Liu C H, Lai Y H, et al.Association of Serum Indoxyl Sulfate Levels with Skeletal Muscle Mass and Strength in Chronic Hemodialysis Patients: A 2-year Longitudinal Analysis[J].Calcif Tissue Int, 2020, 107(3):257-265

[22] Enoki Y, Watanabe H, Arake R, et al.Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1[J].Scientific Reports, 2016, 6:32084

[23]Changchien C Y, Lin Y H, Cheng Y C, et al.Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades[J].Chem Biol Interact, 2019, 304:43-51

[24]Enoki Y, Watanabe H, Arake R, et al.Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction[J].J Cachexia Sarcopenia Muscle, 2017, 8(5):735-747

[25] Kelly D M, Rothwell P M.Disentangling the Relationship Between Chronic Kidney Disease and Cognitive Disorders[J].Front Neurol, 2022, 13:830064

[26]Yeh Y C, Huang M F, Liang S S, et al.Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease[J].Neurotoxicology, 2016, 53:148-152

[27]Lin Y T, Wu P H, Liang S S, et al.Protein-bound uremic toxins are associated with cognitive function among patients undergoing maintenance hemodialysis[J].Sci Rep, 2019, 9(1):20388

[28] Lin Y T, Wu P H, Tsai Y C, et al.Indoxyl Sulfate Induces Apoptosis through Oxidative Stress and Mitogen-Activated Protein Kinase Signaling Pathway Inhibition in Human Astrocytes[J].Journal of Clinical Medicine, 2019, 8(2):191

[29]Sun C Y, Li J R, Wang Y Y, et al.Indoxyl sulfate caused behavioral abnormality and neurodegeneration in mice with unilateral nephrectomy[J].Aging (Albany NY), 2021, 13(5):6681-6701

[30]Karbowska M, Hermanowicz J M, Tankiewicz-Kwedlo A, et al.Neurobehavioral effects of uremic toxin-indoxyl sulfate in the rat model[J].Sci Rep, 2020, 10(1):9483

[31] Liu W C, Shyu J F, Lin Y F, et al.Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor/MAPK Pathway[J]. International Journal of Molecular Sciences, 2020, 21(20):7483

[32] Shyu J F, Liu W C, Zheng C M, et al.Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis[J]. Int J Mol Sci, 2021, 22(20):11265

[33]Watanabe K, Tominari T, Hirata M, et al.Indoxyl sulfate,a uremic toxin in chronic kidney disease,suppresses both bone formation and bone resorption[J].FEBS Open Bio, 2017, 7(8):1178-1185

[34] Liu W C, Wu C C, Hung Y M, et al.Pleiotropic effects of vitamin D in chronic kidney disease[J]. Clinica Chimica Acta, 2016, 453:1-12

[35]Kanda E, Yoshida M, Sasaki S.Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients[J].BMC Nephrol, 2012, 13:122

[36] Dias G F, Bonan N B, Steiner T M, et al.Indoxyl Sulfate, a Uremic Toxin, Stimulates Reactive Oxygen Species Production and Erythrocyte Cell Death Supposedly by an Organic Anion Transporter 2 (OAT2) and NADPH Oxidase Activity-Dependent Pathways[J].Toxins (Basel), 2018, 10(7):280

[37]Asai H, Hirata J, Hirano A, et al.Activation of aryl hydrocarbon receptor mediates suppression of hypoxia-inducible factor-dependent erythropoietin expression by indoxyl sulfate[J].Am J Physiol Cell Physiol, 2016, 310(2):C142-50

[38]Wu C J, Chen C Y, Lai T S, et al.The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease[J].Oncotarget, 2017, 8(47):83030-83037

[39] Lima J D, Guedes M, Rodrigues S D, et al. High-volume hemodiafiltration decreases the pre-dialysis concentrations of indoxyl sulfate and p-cresyl sulfate compared to hemodialysis: a post-hoc analysis from the HDFit randomized controlled trial[J]. J Nephrol, 2022

[40] Shi Y, Tian H, Wang Y, et al.Improved Dialysis Removal of Protein-Bound Uraemic Toxins with a Combined Displacement and Adsorption Technique[J].Blood Purif, 2021, :1-11

[41]Liu J, Zhong J, Yang H, et al.Biotic Supplements in Patients With Chronic Kidney Disease: Meta-Analysis of Randomized Controlled Trials[J].J Ren Nutr, 2022, 32(1):10-21

[42] Mcfarlane C, Krishnasamy R, Stanton T, et al.Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): A Feasibility Randomized Controlled Trial[J].Nutrients, 2021, 13(12):4481

[43]Asai M, Kumakura S, Kikuchi M.Review of the efficacy of AST-120 (KREMEZIN((R))) on renal function in chronic kidney disease patients[J].Ren Fail, 2019, 41(1):47-56

[44]Saar-Kovrov V, Zidek W, Orth-Alampour S, et al.Reduction of protein-bound uraemic toxins in plasma of chronic renal failure patients: A systematic review[J].J Intern Med, 2021, 290(3):499-526

[45]胡文兴, 刘敏.益生菌对维持性血液透析慢性肾脏病患者肠道菌群失调的影响[J].中国微生态学杂志, 2020, 32(11):1323-1326

[46] Mcfarlane C, Krishnasamy R, Stanton T, et al. Diet Quality and Protein-Bound Uraemic Toxins: Investigation of Novel Risk Factors and the Role of Microbiome in Chronic Kidney Disease[J]. J Ren Nutr, 2021
文章导航

/

[an error occurred while processing this directive]